RNXT logo

RNXT
RenovoRx Inc

3,283
Mkt Cap
$39.72M
Volume
119,407.00
52W High
$1.45
52W Low
$0.7006
PE Ratio
-2.66
RNXT Fundamentals
Price
$0.8823
Prev Close
$0.8816
Open
$0.881
50D MA
$0.9389
Beta
0.89
Avg. Volume
304,995.68
EPS (Annual)
-$0.3161
P/B
3.53
Rev/Employee
$66,058.82
$22.87
Loading...
Loading...

About

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in 2009 and is headquartered in Mountain View, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
17

Frequently Asked Questions

What is Market Cap of RenovoRx Inc?
What is the 52-week high for RenovoRx Inc?
What is the 52-week low for RenovoRx Inc?
What is RenovoRx Inc stock price today?
What was RenovoRx Inc stock price yesterday?
What is the PE ratio of RenovoRx Inc?
What is the Price-to-Book ratio of RenovoRx Inc?
What is the 50-day moving average of RenovoRx Inc?
How many employees does RenovoRx Inc have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available